Fuso Pharmaceutical Industries,Ltd. (TYO:4538)
Japan
· Delayed Price · Currency is JPY 2,096.00
-1.00 (-0.05%)
Jul 4, 2025, 3:30 PM JST
TYO:4538 Revenue
In the fiscal year ending March 31, 2025, Fuso Pharmaceutical Industries,Ltd. had annual revenue of 60.56B JPY with 9.31% growth. Fuso Pharmaceutical Industries,Ltd. had revenue of 11.05B in the quarter ending March 31, 2013, with 3.60% growth.
Revenue
60.56B
Revenue Growth
+29.31%
P/S Ratio
0.30
Revenue / Employee
44.21M
Employees
1,370
Market Cap
17.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 60.56B | 5.16B | 9.31% |
| Mar 31, 2024 | 55.41B | 6.80B | 13.98% |
| Mar 31, 2013 | 48.61B | 4.25B | 9.59% |
| Mar 31, 2012 | 44.36B | -3.11B | -6.55% |
| Mar 31, 2011 | 47.47B | 909.00M | 1.95% |
| Mar 31, 2010 | Pro | Pro | Pro |
| Mar 31, 2009 | Pro | Pro | Pro |
| Mar 31, 2008 | Pro | Pro | Pro |
| Mar 31, 2007 | Pro | Pro | Pro |
| Mar 31, 2006 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 866.03B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |